h2.Technology in Diagnostics for Urological Cancer

12 February 2010
Heath Technologies & Medicines KTN
Bristol, UK

The symposium will highlight the clinical need for new urological cancer diagnostics in the context of today’s NHS, and showcase emerging technologies to address these needs. The event will be of interest to health professionals, researchers and industry.

For more information
Urszula Strzemiecka on 0117 32 81110 or info@biosensingtech.com